Kazia Therapeutics Limited (KZIA)
Total Valuation
KZIA has a market cap or net worth of $14.13 million. The enterprise value is $11.85 million.
Market Cap | 14.13M |
Enterprise Value | 11.85M |
Important Dates
The next estimated earnings date is Friday, December 8, 2023, before market open.
Earnings Date | Dec 8, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
KZIA has 23.63 million shares outstanding.
Shares Outstanding | 23.63M |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 1.17% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 891.04 |
Forward PS | n/a |
PB Ratio | 1.77 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 747.17 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.15.
Current Ratio | 1.42 |
Quick Ratio | 1.21 |
Debt / Equity | 0.15 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -135.00% and return on invested capital (ROIC) is -174.23%.
Return on Equity (ROE) | -135.00% |
Return on Assets (ROA) | -64.00% |
Return on Capital (ROIC) | -174.23% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | -179,519 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.92% in the last 52 weeks. The beta is 2.16, so KZIA's price volatility has been higher than the market average.
Beta (1Y) | 2.16 |
52-Week Price Change | -1.92% |
50-Day Moving Average | 0.76 |
200-Day Moving Average | 1.01 |
Relative Strength Index (RSI) | 41.64 |
Average Volume (30 Days) | 70,326 |
Short Selling Information
Short Interest | 5,738 |
Short Previous Month | 113,747 |
Short % of Shares Out | 0.12% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.08 |
Income Statement
In the last 12 months, KZIA had revenue of $15,862 and -$14.11 million in losses. Loss per share was -$0.74.
Revenue | 15,862 |
Gross Profit | 15,236 |
Operating Income | -15.98M |
Pretax Income | -13.74M |
Net Income | -14.11M |
EBITDA | -12.50M |
EBIT | -13.74M |
Loss Per Share | -$0.74 |
Balance Sheet
The company has $3.47 million in cash and $1.19 million in debt, giving a net cash position of $2.28 million or $0.10 per share.
Cash & Cash Equivalents | 3.47M |
Total Debt | 1.19M |
Net Cash | 2.28M |
Net Cash Per Share | $0.10 |
Equity / Book Value | 7.98M |
Book Value Per Share | 0.34 |
Working Capital | 2.12M |
Cash Flow
Operating Cash Flow | -10.04M |
Capital Expenditures | n/a |
Free Cash Flow | -10.04M |
FCF Per Share | -$0.61 |
Margins
Gross margin is 96.05%, with operating and profit margins of -100,747.06% and -88,978.65%.
Gross Margin | 96.05% |
Operating Margin | -100,747.06% |
Pretax Margin | -86,598.03% |
Profit Margin | -88,978.65% |
EBITDA Margin | -78,792.68% |
EBIT Margin | -86,598.03% |
FCF Margin | -63,294.74% |
Dividends & Yields
KZIA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -99.86% |
FCF Yield | -71.03% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -72.74% |
Shareholder Yield | -72.74% |
Analyst Forecast
The average price target for KZIA is $2.00, which is 234.45% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $2.00 |
Price Target Difference | 234.45% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | 387.84% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 14, 2017. It was a reverse split with a ratio of 1:4.
Last Split Date | Jul 14, 2017 |
Split Type | Reverse |
Split Ratio | 1:4 |
Scores
KZIA has an Altman Z-Score of -5.94 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -5.94 |
Piotroski F-Score | 1 |